Original article—liver, pancreas, and biliary tract
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography

https://doi.org/10.1016/j.cgh.2007.06.012Get rights and content

Background & Aims: Accurate detection of hepatic fibrosis is crucial for assessing prognosis and candidacy for treatment in patients with chronic liver disease. Magnetic resonance (MR) elastography, a technique for quantitatively assessing the mechanical properties of soft tissues, has been shown previously to have potential for noninvasively detecting liver fibrosis. The goal of this work was to obtain preliminary estimates of the sensitivity and specificity of the technique in diagnosing liver fibrosis, and to assess its potential for identifying patients who potentially can avoid a biopsy procedure. Methods: MR elastography was performed in 35 normal volunteers and 50 patients with chronic liver disease. MR imaging measurements of hepatic fat to water ratios were obtained to assess the potential for fat infiltration to affect stiffness-based detection of fibrosis. Results: Liver stiffness increased systematically with fibrosis stage. Receiver operating curve analysis showed that, with a shear stiffness cut-off value of 2.93 kilopascals, the predicted sensitivity and specificity for detecting all grades of liver fibrosis is 98% and 99%, respectively. Receiver operating curve analysis also provided evidence that MR elastography can discriminate between patients with moderate and severe fibrosis (grades 2–4) and those with mild fibrosis (sensitivity, 86%; specificity, 85%). Hepatic stiffness does not appear to be influenced by the degree of steatosis. Conclusions: MR elastography is a safe, noninvasive technique with excellent diagnostic accuracy for assessing hepatic fibrosis. Based on the high negative predictive value of MR elastography, an initial clinical application may be to triage patients who are under consideration for biopsy examination to assess possible hepatic fibrosis.

Section snippets

Patient Population

Subjects undergoing clinical evaluation and management for chronic liver disease at the Mayo Clinic (Rochester, MN) between August 4, 2005, and March 10, 2007, were eligible for study participation. Inclusion criteria were as follows: (1) age 18 years or older, (2) percutaneous liver biopsy performed within 1 year of study enrollment (average time interval, 6.5 ± 3.9 mo; range, 0–12 mo), and/or (3) a diagnosis of compensated cirrhosis supported by liver histology or compatible clinical and

Patient and Volunteer Demographics and Diagnoses

Thirty-five volunteers (28% women; mean age, 37.2 ± 17.8 y; range, 19–82 y; mean body mass index, 23.6 ± 3.8 kg/m2; body mass index range, 17.9–34.8 kg/m2) with no history of liver disease and 50 patients (54% women; mean age, 55.3 ± 11.2 y; range, 21–76 y) with chronic liver disease consented to undergo MR elastography. Among patients, the major causes of chronic liver disease included chronic hepatitis C (33%), nonalcoholic fatty liver disease (20%), autoimmune hepatitis (7%), primary biliary

Discussion

The results of this study support the hypothesis that MR elastography is effective for distinguishing normal from fibrotic livers with a very high negative predictive value of 97%. It appears to be very good at differentiating normal from mild fibrosis (F0–2), and mild fibrosis (F0–2) from severe fibrosis (F3–4). The presence of steatosis does not appear to affect shear stiffness measurements.

Liver stiffness assessed by MR elastography was highly consistent among normal individuals with a mean

Conclusions

The detection of hepatic fibrosis by MR elastography appears safe and feasible in human subjects with chronic liver disease. Furthermore, this method is highly sensitive and specific for detecting intermediate stages of hepatic fibrosis based on the information available from this investigation. The presence of hepatic steatosis had no apparent effect on the liver stiffness measurements. Overall, these results provide continued motivation for further evaluation of hepatic MR elastography in

References (44)

  • A. Manduca et al.

    Magnetic resonance elastography: non-invasive mapping of tissue elasticity

    Med Image Anal

    (2001)
  • E.M. Brunt et al.

    Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

    Am J Gastroenterol

    (1999)
  • P.S. Kamath et al.

    A model to predict survival in patients with end-stage liver disease

    Hepatology

    (2001)
  • A. Manduca et al.

    Spatio-temporal directional filtering for improved inversion of MR elastography images

    Med Image Anal

    (2003)
  • N.J. Shaheen et al.

    The burden of gastrointestinal and liver diseases, 2006

    Am J Gastroenterol

    (2006)
  • R.A. Standish et al.

    An appraisal of the histopathological assessment of liver fibrosis

    Gut

    (2006)
  • A.A. Bravo et al.

    Liver biopsy

    N Engl J Med

    (2001)
  • S.L. Friedman et al.

    Reversal of hepatic fibrosis—fact or fantasy?

    Hepatology

    (2006)
  • J.H. Chen et al.

    Magnetization transfer contrast imaging of liver cirrhosis

    Hepatogastroenterology

    (1999)
  • T. Nishizaki et al.

    Significance of intraoperative measurement of liver consistency prior to hepatic resection

    Hepatogastroenterology

    (1995)
  • M. Ziol et al.

    Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C

    Hepatology

    (2005)
  • M. Hernandez-Guerra et al.

    Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension

    J Clin Gastroenterol

    (2005)
  • Cited by (794)

    • Differentiation of bladder cancer with water flow elastography (WaFE)

      2024, Journal of the Mechanical Behavior of Biomedical Materials
    View all citing articles on Scopus

    Supported by National Institutes of Health grant EB001981. P.J.R. and R.L.E. and their institution hold patents related to this technology and have a potential financial interest in this research.

    View full text